01
Cash & equivalents increased 271.2%
Cash & equivalents changed +271.2% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
$33.9M→$125.8MComparable → current
· Pharmaceutical Preparations
RESEARCH SNAPSHOTViking Therapeutics, Inc.'s latest supported as-filed period reports revenue of $0. Every value below links to its SEC accession and metric lineage.
The most important deterministic changes, ranked by magnitude, issuer history, persistence, and accounting profile.
Cash & equivalents changed +271.2% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Net income changed -95.3% from the comparable as-filed period.
Operating income changed -77.8% from the comparable as-filed period.
Each point keeps the date investors could first observe it and its accession.
VKTX · as filed with the SEC · reported-date aware
Direct SEC links, filing dates, report periods, and amendment flags.
0002144542-26-000004SEC ↗4Jul 29, 2026Period Jul 28, 20260001193125-26-324448SEC ↗4Jul 29, 2026Period Jul 28, 20260001193125-26-324447SEC ↗4Jul 29, 2026Period Jul 28, 20260001193125-26-324446SEC ↗10-QJul 29, 2026Period Jun 30, 20260001193125-26-324219SEC ↗8-KJul 29, 2026Period Jul 29, 20260001193125-26-323652SEC ↗4Jun 3, 2026Period Jun 1, 20260001193125-26-256039SEC ↗Transaction semantics distinguish purchases, sales, awards, exercises, withholding, and derivatives.
GrossPattern stores immutable raw artifacts, accession-scoped facts, parser and metric versions, dependency edges, quality state, and channel-specific publication rights. A restricted or unknown ancestor blocks the page and API automatically.
SEC source policy ↗Research & development changed +92.4% from the comparable as-filed period.
Revenue changed +0.0% from the comparable as-filed period.
Stock-based compensation changed -17.8% from the comparable as-filed period.
Method note “Materiality” here is an analytical magnitude band, not a legal conclusion. Full filing-text semantic changes remain unpublished while excerpt rights and review thresholds are unresolved.
Latest supported period in this snapshot: 2026-06-30. Duration facts use direct quarterly or annual SEC contexts; GrossPattern does not manufacture missing Q4 values.
0001193125-26-239535